IDEXX Laboratories Inc

NASDAQ IDXX

Download Data

IDEXX Laboratories Inc Market Capitalization on June 03, 2024: USD 40.67 B

IDEXX Laboratories Inc Market Capitalization is USD 40.67 B on June 03, 2024, a 5.26% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • IDEXX Laboratories Inc 52-week high Market Capitalization is USD 47.89 B on February 23, 2024, which is 17.76% above the current Market Capitalization.
  • IDEXX Laboratories Inc 52-week low Market Capitalization is USD 32.50 B on October 27, 2023, which is -20.08% below the current Market Capitalization.
  • IDEXX Laboratories Inc average Market Capitalization for the last 52 weeks is USD 41.65 B.
NASDAQ: IDXX

IDEXX Laboratories Inc

CEO Mr. Jonathan J. Mazelsky
IPO Date June 21, 1991
Location United States
Headquarters One IDEXX Drive, Westbrook, ME, United States, 04092
Employees 11,000
Sector Healthcare
Industry Diagnostics & research
Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Similar companies

WAT

Waters Corporation

NA

NA

CRL

Charles River Laboratories

NA

NA

RVTY

Revvity Inc.

NA

NA

A

Agilent Technologies Inc

NA

NA

DHR

Danaher Corporation

NA

NA

TWST

Twist Bioscience Corp

NA

NA

ICLR

ICON PLC

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email